BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

356 related articles for article (PubMed ID: 29299592)

  • 1. Chemoprevention of Basal and Squamous Cell Carcinoma With a Single Course of Fluorouracil, 5%, Cream: A Randomized Clinical Trial.
    Weinstock MA; Thwin SS; Siegel JA; Marcolivio K; Means AD; Leader NF; Shaw FM; Hogan D; Eilers D; Swetter SM; Chen SC; Jacob SE; Warshaw EM; Stricklin GP; Dellavalle RP; Sidhu-Malik N; Konnikov N; Werth VP; Keri JE; Robinson-Bostom L; Ringer RJ; Lew RA; Ferguson R; DiGiovanna JJ; Huang GD;
    JAMA Dermatol; 2018 Feb; 154(2):167-174. PubMed ID: 29299592
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term Efficacy of Topical Fluorouracil Cream, 5%, for Treating Actinic Keratosis: A Randomized Clinical Trial.
    Pomerantz H; Hogan D; Eilers D; Swetter SM; Chen SC; Jacob SE; Warshaw EM; Stricklin G; Dellavalle RP; Sidhu-Malik N; Konnikov N; Werth VP; Keri J; Lew R; Weinstock MA;
    JAMA Dermatol; 2015 Sep; 151(9):952-60. PubMed ID: 25950503
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of topical fluorouracil cream on costs of treating keratinocyte carcinoma (nonmelanoma skin cancer) and actinic keratosis.
    Yoon J; Phibbs CS; Chow A; Weinstock MA;
    J Am Acad Dermatol; 2018 Sep; 79(3):501-507.e2. PubMed ID: 29505863
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tolerability of high-dose topical tretinoin: the Veterans Affairs Topical Tretinoin Chemoprevention Trial.
    Geng A; Weinstock MA; Hall R; Eilers D; Naylor M; Kalivas J;
    Br J Dermatol; 2009 Oct; 161(4):918-24. PubMed ID: 19681859
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characteristics of Keratinocyte Carcinomas and Patients with Keratinocyte Carcinomas Following a Single 2-4 Week Course of Topical 5-fluorouracil on the Face and Ears.
    Beatson M; Means AD; Leader NF; Robinson-Bostom L; Weinstock MA
    Acta Derm Venereol; 2019 Jun; 99(7):707-708. PubMed ID: 30896781
    [No Abstract]   [Full Text] [Related]  

  • 6. Effect of Topical Fluorouracil Cream on Photodamage: Secondary Analysis of a Randomized Clinical Trial.
    Korgavkar K; Lee KC; Weinstock MA;
    JAMA Dermatol; 2017 Nov; 153(11):1142-1146. PubMed ID: 28877312
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between statin use and risk for keratinocyte carcinoma in the veterans affairs topical tretinoin chemoprevention trial.
    Dore DD; Lapane KL; Trivedi AN; Mor V; Weinstock MA
    Ann Intern Med; 2009 Jan; 150(1):9-18. PubMed ID: 19124815
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of selenium supplementation for cancer prevention in patients with carcinoma of the skin. A randomized controlled trial. Nutritional Prevention of Cancer Study Group.
    Clark LC; Combs GF; Turnbull BW; Slate EH; Chalker DK; Chow J; Davis LS; Glover RA; Graham GF; Gross EG; Krongrad A; Lesher JL; Park HK; Sanders BB; Smith CL; Taylor JR
    JAMA; 1996 Dec; 276(24):1957-63. PubMed ID: 8971064
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tretinoin and the prevention of keratinocyte carcinoma (Basal and squamous cell carcinoma of the skin): a veterans affairs randomized chemoprevention trial.
    Weinstock MA; Bingham SF; Digiovanna JJ; Rizzo AE; Marcolivio K; Hall R; Eilers D; Naylor M; Kirsner R; Kalivas J; Cole G; Vertrees JE;
    J Invest Dermatol; 2012 Jun; 132(6):1583-90. PubMed ID: 22318383
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rate and Proportion of Malignant Skin Biopsies for Basal Cell and Squamous Cell Carcinoma on the Face and Ears After a Single Course of Topical 5-Fluorouracil: The Veterans Affairs Keratinocyte Carcinoma Chemoprevention Trial.
    Means AD; Leader NF; Siegel JA; Arron ST; Walker JL; Pomerantz H; Beatson M; Weinstock MA
    Dermatol Surg; 2021 Apr; 47(4):541-543. PubMed ID: 33795573
    [No Abstract]   [Full Text] [Related]  

  • 11. Comparison of topical methyl aminolevulinate photodynamic therapy with cryotherapy or Fluorouracil for treatment of squamous cell carcinoma in situ: Results of a multicenter randomized trial.
    Morton C; Horn M; Leman J; Tack B; Bedane C; Tjioe M; Ibbotson S; Khemis A; Wolf P
    Arch Dermatol; 2006 Jun; 142(6):729-35. PubMed ID: 16785375
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of ACE inhibitors and angiotensin receptor blockers with keratinocyte cancer prevention in the randomized VATTC trial.
    Christian JB; Lapane KL; Hume AL; Eaton CB; Weinstock MA;
    J Natl Cancer Inst; 2008 Sep; 100(17):1223-32. PubMed ID: 18728281
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Topical tretinoin therapy and all-cause mortality.
    Weinstock MA; Bingham SF; Lew RA; Hall R; Eilers D; Kirsner R; Naylor M; Kalivas J; Cole G; Marcolivio K; Collins J; Digiovanna JJ; Vertrees JE;
    Arch Dermatol; 2009 Jan; 145(1):18-24. PubMed ID: 19153339
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Photodynamic therapy versus topical imiquimod versus topical fluorouracil for treatment of superficial basal-cell carcinoma: a single blind, non-inferiority, randomised controlled trial.
    Arits AH; Mosterd K; Essers BA; Spoorenberg E; Sommer A; De Rooij MJ; van Pelt HP; Quaedvlieg PJ; Krekels GA; van Neer PA; Rijzewijk JJ; van Geest AJ; Steijlen PM; Nelemans PJ; Kelleners-Smeets NW
    Lancet Oncol; 2013 Jun; 14(7):647-54. PubMed ID: 23683751
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of new keratinocyte carcinomas on skin-related quality of life: Results from the Veterans Affairs Keratinocyte Carcinoma Chemoprevention Trial.
    Siegel JA; Beatson M; Chren MM; Weinstock MA;
    J Am Acad Dermatol; 2019 May; 80(5):1458-1459. PubMed ID: 30639882
    [No Abstract]   [Full Text] [Related]  

  • 16. Facial resurfacing for nonmelanoma skin cancer prophylaxis.
    Hantash BM; Stewart DB; Cooper ZA; Rehmus WE; Koch RJ; Swetter SM
    Arch Dermatol; 2006 Aug; 142(8):976-82. PubMed ID: 16924046
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative effectiveness of treatment of actinic keratosis with topical fluorouracil and imiquimod in the prevention of keratinocyte carcinoma: A cohort study.
    Neugebauer R; Su KA; Zhu Z; Sokil M; Chren MM; Friedman GD; Asgari MM
    J Am Acad Dermatol; 2019 Apr; 80(4):998-1005. PubMed ID: 30458208
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictors of squamous cell carcinoma in high-risk patients in the VATTC trial.
    Xiong MY; Rizzo AE; Cohen TS; Dyer RK; Korgavkar K; Bingham SF; Weinstock MA;
    J Invest Dermatol; 2013 Jun; 133(6):1521-32. PubMed ID: 23348836
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Five-Year Results of a Randomized Controlled Trial Comparing Effectiveness of Photodynamic Therapy, Topical Imiquimod, and Topical 5-Fluorouracil in Patients with Superficial Basal Cell Carcinoma.
    Jansen MHE; Mosterd K; Arits AHMM; Roozeboom MH; Sommer A; Essers BAB; van Pelt HPA; Quaedvlieg PJF; Steijlen PM; Nelemans PJ; Kelleners-Smeets NWJ
    J Invest Dermatol; 2018 Mar; 138(3):527-533. PubMed ID: 29045820
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of increased actinic keratosis count on skin-related quality of life: results from the Veterans Affairs Keratinocyte Carcinoma Chemoprevention (VAKCC) Trial.
    Beatson M; Siegel JA; Chren MM; Weinstock MA
    Eur J Dermatol; 2019 Oct; 29(5):507-510. PubMed ID: 31647464
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.